NeuroPace Inc. (NPCE)
NeuroPace Statistics
Share Statistics
NeuroPace has 32.56M shares outstanding. The number of shares has increased by 5.3% in one year.
| Shares Outstanding | 32.56M |
| Shares Change (YoY) | 5.3% |
| Shares Change (QoQ) | 2.23% |
| Owned by Institutions (%) | 70.87% |
| Shares Floating | 23M |
| Failed to Deliver (FTD) Shares | 139 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 267K, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 267K |
| Short % of Shares Out | 0.89% |
| Short % of Float | 1.9% |
| Short Ratio (days to cover) | 3.09 |
Valuation Ratios
The PE ratio is -12.01 and the forward PE ratio is -15.68. NeuroPace's PEG ratio is 0.45.
| PE Ratio | -12.01 |
| Forward PE | -15.68 |
| PS Ratio | 4.08 |
| Forward PS | 1.6 |
| PB Ratio | 40.67 |
| P/FCF Ratio | -18.16 |
| PEG Ratio | 0.45 |
Enterprise Valuation
NeuroPace Inc. has an Enterprise Value (EV) of 320.87M.
| EV / Earnings | -11.82 |
| EV / Sales | 4.02 |
| EV / EBITDA | -19.36 |
| EV / EBIT | -14.81 |
| EV / FCF | -17.88 |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 9.15.
| Current Ratio | 5.37 |
| Quick Ratio | 4.48 |
| Debt / Equity | 9.15 |
| Total Debt / Capitalization | 90.15 |
| Cash Flow / Debt | -0.24 |
| Interest Coverage | -2.46 |
Financial Efficiency
Return on equity (ROE) is -3.39% and return on capital (ROIC) is -26.64%.
| Return on Equity (ROE) | -3.39% |
| Return on Assets (ROA) | -0.29% |
| Return on Capital (ROIC) | -26.64% |
| Revenue Per Employee | $434,271.74 |
| Profits Per Employee | $-147,505.43 |
| Employee Count | 184 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -10.3% in the last 52 weeks. The beta is 2.07, so NeuroPace's price volatility has been higher than the market average.
| Beta | 2.07 |
| 52-Week Price Change | -10.3% |
| 50-Day Moving Average | 12.63 |
| 200-Day Moving Average | 9.25 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 232.42K |
Income Statement
In the last 12 months, NeuroPace had revenue of 79.91M and earned -27.14M in profits. Earnings per share was -0.93.
| Revenue | 79.91M |
| Gross Profit | 59.09M |
| Operating Income | -21.67M |
| Net Income | -27.14M |
| EBITDA | -16.57M |
| EBIT | -21.67M |
| Earnings Per Share (EPS) | -0.93 |
Balance Sheet
The company has 13.43M in cash and 73.34M in debt, giving a net cash position of -59.91M.
| Cash & Cash Equivalents | 13.43M |
| Total Debt | 73.34M |
| Net Cash | -59.91M |
| Retained Earnings | -530.95M |
| Total Assets | 94.65M |
| Working Capital | 66.18M |
Cash Flow
In the last 12 months, operating cash flow was -17.95M and capital expenditures 0, giving a free cash flow of -17.95M.
| Operating Cash Flow | -17.95M |
| Capital Expenditures | 0 |
| Free Cash Flow | -17.95M |
| FCF Per Share | -0.62 |
Margins
Gross margin is 73.94%, with operating and profit margins of -27.12% and -33.97%.
| Gross Margin | 73.94% |
| Operating Margin | -27.12% |
| Pretax Margin | -33.97% |
| Profit Margin | -33.97% |
| EBITDA Margin | -20.74% |
| EBIT Margin | -27.12% |
| FCF Margin | -22.46% |
Dividends & Yields
NPCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.85% |
| FCF Yield | -4.66% |
Analyst Forecast
The average price target for NPCE is $17, which is 43.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $17 |
| Price Target Difference | 43.6% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -4.02 |
| Piotroski F-Score | 3 |